HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ramakrishna P Alur Selected Research

Rufous oculocutaneous albinism

10/2018Minimal Efficacy of Nitisinone Treatment in a Novel Mouse Model of Oculocutaneous Albinism, Type 3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ramakrishna P Alur Research Topics

Disease

3Coloboma (Colobomas)
01/2020 - 01/2014
3Oculocutaneous Albinism (Albinism, Yellow Mutant)
01/2019 - 10/2011
1Neoplasms (Cancer)
01/2019
1Hypopigmentation (Hypomelanosis)
01/2019
1Eye Abnormalities (Eye Abnormality)
01/2019
1Albinism
01/2019
1Rufous oculocutaneous albinism
10/2018
1Microphthalmos
04/2016
1Ciliopathies
10/2015
1Oculocutaneous albinism type 1
10/2011
1Leber Congenital Amaurosis
06/2010
1Papillorenal syndrome
04/2008

Drug/Important Bio-Agent (IBA)

3Monophenol Monooxygenase (Tyrosinase)IBA
01/2019 - 10/2011
3nitisinone (Orfadin)FDA Link
01/2019 - 10/2011
2Melanins (Melanin)IBA
01/2019 - 10/2011
2Mutant Proteins (Protein, Mutant)IBA
04/2016 - 06/2010
2MorpholinosIBA
10/2015 - 01/2014
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1retinoic acid receptor betaIBA
01/2020
1Retinaldehyde (Retinal)IBA
04/2016
1LigandsIBA
04/2016
1Transcription Factors (Transcription Factor)IBA
04/2016
1PAX2 Transcription FactorIBA
04/2008